Patent 7605237 was granted and assigned to Regeneron Pharmaceuticals, Inc. on October, 2009 by the United States Patent and Trademark Office.
An isolated human antibody or antibody fragment thereof which binds to human interleukin-4 receptor alpha (hIL-4Rα) with an affinity constant (KD) of less than 200 pM, as measured by surface plasmon resonance.